AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36187365 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week online multicomponent stress reduction intervention including yoga, breathwork, meditation videos, cognitive behavioral therapy activities, and check-ins.
Number of subjects: 101
Study 36187365 — intervention group
Group type: COMPARATOR
Intervention: Control group received weekly motivational messages by email.
Number of subjects: 101
Study 33278859 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue injection with combination therapy
Number of subjects: 119
Study 33278859 — intervention group
Group type: COMPARATOR
Intervention: Fibrin glue injection without combination therapy
Number of subjects: 119
Study 33278859 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue injection (overall population)
Number of subjects: 119
Study 34323681 — intervention group
Group type: EXPERIMENTAL
Intervention: lenabasum 5 mg twice daily
Number of subjects: 365
Study 34323681 — intervention group
Group type: EXPERIMENTAL
Intervention: lenabasum 20 mg twice daily
Number of subjects: 365
Study 34323681 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 365
Study 32066487 — intervention group
Group type: EXPERIMENTAL
Intervention: Gyejibongnyeong-Hwan (GBH) for 8 weeks
Number of subjects: 40
Study 32066487 — intervention group
Group type: COMPARATOR
Intervention: Gyejibongnyeong-Hwan (GBH) after 8 weeks of controlled waiting
Number of subjects: 40
Study 35416465 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000mg metamizole + 400mg ibuprofen
Number of subjects: 35
Study 33962504 — intervention group
Group type: EXPERIMENTAL
Intervention: Immature poken extract (IPE)
Number of subjects: 20
Study 33609324 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of drug treatment quality by three specialist physicians and two resident physicians
Number of subjects: 30
Study 33609324 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of the association between drug treatment and hospital admission
Number of subjects: 30
Study 32842975 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised and individually adapted exercise intervention (12 weeks of biweekly exercise including aerobic and strengthening exercises)
Number of subjects: 120
Study 32842975 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised and individually adapted exercise intervention
Number of subjects: 120
Study 32842975 — intervention group
Group type: COMPARATOR
Intervention: Oral and written information about a home-based exercise programme (Control)
Number of subjects: 120
Study 35100776 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Aid (CA)
Number of subjects: 0
Study 35100776 — intervention group
Group type: COMPARATOR
Intervention: Non-Cognitive Aid (non-CA)
Number of subjects: 0
Study 34264860 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus normal dose of Chinese herbal fumigation steam therapy (CHFST)
Number of subjects: 42
Study 34264860 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus one-sixteenth of a normal dose of CHFST
Number of subjects: 42
Study 34264860 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture only (Control group)
Number of subjects: 42
Study 35218194 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar reduction intervention (goal of ≤10% of calories from free sugar) for 12 weeks
Number of subjects: 105
Study 35218194 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard dietary advice)
Number of subjects: 105
Study 35218194 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar reduction intervention
Number of subjects: 105
Study 35218194 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 105
Study 35218194 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with whole-body fat mass (FM) reduction (irrespective of randomization)
Number of subjects: 105
Study 33523081 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered-tip toothbrush
Number of subjects: 70
Study 33523081 — intervention group
Group type: COMPARATOR
Intervention: End-rounded toothbrush
Number of subjects: 70
Study 36306128 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative-based psychoeducational intervention (8-week program with nurse-led interactive video sessions)
Number of subjects: 608
Study 36306128 — intervention group
Group type: COMPARATOR
Intervention: Didactic education (4 nurse-led sessions)
Number of subjects: 608
Study 34148146 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (4 × 3 min at 90% VO2max interspersed with 3 min at 60% VO2max)
Number of subjects: 29
Study 34148146 — intervention group
Group type: EXPERIMENTAL
Intervention: VICT (25 min at 70% VO2max)
Number of subjects: 29
Study 34148146 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 29
Study 34148146 — intervention group
Group type: EXPERIMENTAL
Intervention: VICT
Number of subjects: 29
Study 34330860 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter study duration, fewer prompts, shorter prompts, and higher compensation
Number of subjects: 600
Study 34330860 — intervention group
Group type: COMPARATOR
Intervention: Intensive study design features (longer duration, more prompts, longer prompts, lower compensation)
Number of subjects: 600
Study 33109190 — intervention group
Group type: EXPERIMENTAL
Intervention: STAND+ (multilevel intervention with sit-stand workstations)
Number of subjects: 630
Study 33109190 — intervention group
Group type: COMPARATOR
Intervention: MOVE+ (multilevel intervention targeting reduction in sedentary time and increases in light physical activity)
Number of subjects: 630
Study 35125265 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based therapy (GT)
Number of subjects: 135
Study 35125265 — intervention group
Group type: EXPERIMENTAL
Intervention: Email-delivered self-help cognitive behavioral therapy (ESH)
Number of subjects: 135
Study 34129709 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 255
Study 34129709 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Number of subjects: 255
Study 34129709 — intervention group
Group type: EXPERIMENTAL
Intervention: Pessary
Number of subjects: 255
Study 34129709 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerclage
Number of subjects: 255
Study 34129709 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of treatments
Number of subjects: 255
Study 32682429 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention including teaching materials on aseptic procedures, flexibly mountable alcoholic hand rub dispensers, and quarterly feedback on HH compliance.
Number of subjects: 20
Study 32682429 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 20
Study 32682429 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention.
Number of subjects: 20
Study 35641409 — intervention group
Group type: EXPERIMENTAL
Intervention: Isatuximab plus pomalidomide and dexamethasone (Isa-Pd)
Number of subjects: 36
Study 35641409 — intervention group
Group type: COMPARATOR
Intervention: Pomalidomide and dexamethasone (Pd)
Number of subjects: 36
Study 34128526 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX) injections
Number of subjects: 40
Study 34128526 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (normal saline) injections
Number of subjects: 40
Study 32144053 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell salvage
Number of subjects: 716
Study 32144053 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 716
Study 32144053 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic transfusion
Number of subjects: 716
Study 32144053 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed cell salvage blood
Number of subjects: 716
Study 34756640 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal Splints (OS)
Number of subjects: 140
Study 34756640 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US)
Number of subjects: 140
Study 34756640 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐Intensity Laser Therapy (HILT)
Number of subjects: 140
Study 34756640 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 140
Study 32349662 — intervention group
Group type: EXPERIMENTAL
Intervention: Triptan insufficient responders (TIRs)
Number of subjects: 1413
Study 32349662 — intervention group
Group type: COMPARATOR
Intervention: Triptan responders (TRs)
Number of subjects: 1413
Study 35404684 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuzuloparib (150 mg, twice daily)
Number of subjects: 252
Study 35404684 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study 33731311 — intervention group
Group type: EXPERIMENTAL
Intervention: Early palliative care (EPC)
Number of subjects: 23
Study 33731311 — intervention group
Group type: COMPARATOR
Intervention: Standard oncologic care (SOC)
Number of subjects: 23
Study 35266296 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin
Number of subjects: 8246
Study 35266296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8246
Study 33656232 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-assisted health education
Number of subjects: 70
Study 33656232 — intervention group
Group type: COMPARATOR
Intervention: Leaflet group (control)
Number of subjects: 70
Study 37036305 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric Opioid Analgesia Self-Instruction System (PedOASIS)
Number of subjects: 64
Study 37036305 — intervention group
Group type: COMPARATOR
Intervention: Usual PHO training (control)
Number of subjects: 64
Study 33142249 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.4 μg/ml
Number of subjects: 150
Study 33142249 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 μg/ml
Number of subjects: 150
Study 33142249 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.6 μg/ml
Number of subjects: 150
Study 33142249 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine 0 μg/ml
Number of subjects: 150
Study 33142249 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine 0.3 μg/ml
Number of subjects: 150
Study 32592381 — intervention group
Group type: EXPERIMENTAL
Intervention: 20Gy/5fr
Number of subjects: 22
Study 32592381 — intervention group
Group type: COMPARATOR
Intervention: 27Gy/3fr
Number of subjects: 22
Study 34533758 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI 25.0-29.9 kg/m2
Number of subjects: 4956
Study 34533758 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI 30.0-34.9 kg/m2
Number of subjects: 4956
Study 34533758 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI 35.0-39.9 kg/m2
Number of subjects: 4956
Study 34533758 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥ 40.0 kg/m2
Number of subjects: 4956
Study 34533758 — intervention group
Group type: COMPARATOR
Intervention: Normal BMI (18.5-24.9 kg/m2)
Number of subjects: 4956
Study 34533758 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity (BMI ≥ 30.0 kg/m2)
Number of subjects: 4956
Study 34533758 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity (BMI 30.0-34.9 kg/m2)
Number of subjects: 4956
Study 34533758 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity (BMI 35.0-39.9 kg/m2)
Number of subjects: 4956
Study 33751402 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS administration
Number of subjects: 10
Study 33751402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 35320921 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation (ASCT)
Number of subjects: 174
Study 35320921 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ASCT)
Number of subjects: 174
Study 35320921 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation (ASCT) in advanced stage subgroup
Number of subjects: 174
Study 35320921 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ASCT) in advanced stage subgroup
Number of subjects: 174
Study 32217780 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 202
Study 32217780 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV
Number of subjects: 202
Study 34225347 — intervention group
Group type: EXPERIMENTAL
Intervention: REBOA-RATE assessment
Number of subjects: 42
Study 33031148 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention associated mortality
Number of subjects: 101
Study 33031148 — intervention group
Group type: COMPARATOR
Intervention: Control group mortality
Number of subjects: 101
Study 33031148 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute risk reduction
Number of subjects: 101
Study 33031148 — intervention group
Group type: COMPARATOR
Intervention: Clinically important treatment benefit or harm
Number of subjects: 101
Study 35907504 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose Prasugrel or Clopidogrel
Number of subjects: 1364
Study 34668436 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 g of ketone ester (KE)
Number of subjects: 14
Study 34668436 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg/kg body mass bicarbonate (BIC)
Number of subjects: 14
Study 34668436 — intervention group
Group type: EXPERIMENTAL
Intervention: KE + BIC
Number of subjects: 14
Study 34668436 — intervention group
Group type: COMPARATOR
Intervention: Control drink with 60 g of carbohydrates/h
Number of subjects: 14
Study 35246135 — intervention group
Group type: EXPERIMENTAL
Intervention: LOCI intervention
Number of subjects: 47
Study 35246135 — intervention group
Group type: COMPARATOR
Intervention: Non-LOCI conditions
Number of subjects: 47
Study 33824227 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted IBD
Number of subjects: 75000
Study 35317870 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic gargles for 14 days post-surgery
Number of subjects: 30
Study 35317870 — intervention group
Group type: COMPARATOR
Intervention: Placebo gargles for 14 days post-surgery
Number of subjects: 30
Study 35317870 — intervention group
Group type: COMPARATOR
Intervention: Probiotic and placebo groups
Number of subjects: 30
Study 32852139 — intervention group
Group type: EXPERIMENTAL
Intervention: FKB327 (F)
Number of subjects: 0
Study 32852139 — intervention group
Group type: COMPARATOR
Intervention: Reference Product (RP)
Number of subjects: 0
Study 32852139 — intervention group
Group type: EXPERIMENTAL
Intervention: F-F-F (no switch)
Number of subjects: 0
Study 32852139 — intervention group
Group type: EXPERIMENTAL
Intervention: F-RP-F (single switch)
Number of subjects: 0
Study 32852139 — intervention group
Group type: EXPERIMENTAL
Intervention: RP-F-F (single switch)
Number of subjects: 0
Study 32852139 — intervention group
Group type: EXPERIMENTAL
Intervention: RP-RP-F (double switch)
Number of subjects: 0
Study 36102630 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week postoperative oral antibiotics
Number of subjects: 38
Study 36102630 — intervention group
Group type: COMPARATOR
Intervention: 12-week postoperative oral antibiotics
Number of subjects: 38
Study 33714226 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic control (exenatide and pioglitazone or basal-bolus insulin)
Number of subjects: 41
Study 33714226 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic control in patients with pDPN
Number of subjects: 41
Study 33714226 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic control in patients without pDPN
Number of subjects: 41
Study 33714226 — intervention group
Group type: COMPARATOR
Intervention: Control group (18 participants at baseline only)
Number of subjects: 41
Study 615924469 — intervention group
Group type: COMPARATOR
Intervention: No micro-scotomas
Number of subjects: 5
Study 615924469 — intervention group
Group type: EXPERIMENTAL
Intervention: 39% micro-scotomas at the fovea
Number of subjects: 5
Study 615924469 — intervention group
Group type: EXPERIMENTAL
Intervention: 39% micro-scotomas at 5 deg eccentricity
Number of subjects: 5
Study 615924469 — intervention group
Group type: EXPERIMENTAL
Intervention: 39% micro-scotomas at 10 deg eccentricity
Number of subjects: 5
Study 35037037 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid comprehensive telerehabilitation (HCTR)
Number of subjects: 850
Study 35037037 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 850
Study 34043778 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermic machine perfusion at 70 mmHg (NMP-70)
Number of subjects: 10
Study 34043778 — intervention group
Group type: COMPARATOR
Intervention: Static cold storage
Number of subjects: 10
Study 35538000 — intervention group
Group type: COMPARATOR
Intervention: Standard oral and written information
Number of subjects: 69
Study 35538000 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard oral and written information plus additional educational video
Number of subjects: 69
Study 32976051 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive pâté (4 tablets/day corresponding to 30 mg/day of hydroxytyrosol)
Number of subjects: 19
Study 35144973 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS
Number of subjects: 224
Study 35144973 — intervention group
Group type: COMPARATOR
Intervention: MRCP
Number of subjects: 224
Study 34346827 — intervention group
Group type: EXPERIMENTAL
Intervention: MW33 (4 mg/kg, 10 mg/kg, 20 mg/kg, 40 mg/kg, 60 mg/kg)
Number of subjects: 42
Study 34346827 — intervention group
Group type: EXPERIMENTAL
Intervention: MW33 (10-60 mg/kg)
Number of subjects: 42
Study 34346827 — intervention group
Group type: EXPERIMENTAL
Intervention: MW33
Number of subjects: 42
Study 35648692 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional nursing intervention for pain
Number of subjects: 132
Study 33243172 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth clinical decision-making support system (mCDMSS)
Number of subjects: 16
Study 33243172 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mCDMSS)
Number of subjects: 16
Study 36644732 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) injection
Number of subjects: 17
Study 36644732 — intervention group
Group type: COMPARATOR
Intervention: Aspiration alone
Number of subjects: 17
Study 33483869 — intervention group
Group type: EXPERIMENTAL
Intervention: Premixed bioceramic (BC)
Number of subjects: 76
Study 33483869 — intervention group
Group type: COMPARATOR
Intervention: Mineral trioxide aggregate (MTA)
Number of subjects: 76
Study 32967391 — intervention group
Group type: EXPERIMENTAL
Intervention: PIFB-Pecs II group
Number of subjects: 60
Study 32967391 — intervention group
Group type: COMPARATOR
Intervention: Pecs II group
Number of subjects: 60
Study 36240577 — intervention group
Group type: EXPERIMENTAL
Intervention: Disinhibited eating qualities (including LOC, overeating, eating more than planned, mindless eating, concerns about wasting food, encouragement to eat more)
Number of subjects: 42
Study 36240577 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss of control (LOC) eating
Number of subjects: 42
Study 35267178 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits from birth to age 3 years
Number of subjects: 1090
Study 35267178 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-based early childhood education from ages 1 to 3 years
Number of subjects: 1090
Study 35267178 — intervention group
Group type: COMPARATOR
Intervention: Infant Health and Development Program (IHDP)
Number of subjects: 1090
Study 32958697 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated hs-CRP levels and multiple acute infarctions (MAIs)
Number of subjects: 807
Study 32958697 — intervention group
Group type: COMPARATOR
Intervention: Non-elevated hs-CRP levels and no acute infarction (NAI)
Number of subjects: 807
Study 32958697 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite events
Number of subjects: 807
Study 32232698 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored dose-dense chemotherapy (four cycles of epirubicin and cyclophosphamide every 2 weeks followed by four cycles of docetaxel every 2 weeks)
Number of subjects: 760
Study 32232698 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy (three cycles of fluorouracil and epirubicin-cyclophosphamide every 3 weeks followed by three cycles of docetaxel every 3 weeks)
Number of subjects: 760
Study 36194912 — intervention group
Group type: EXPERIMENTAL
Intervention: Suspended social media use for one week
Number of subjects: 93
Study 36194912 — intervention group
Group type: COMPARATOR
Intervention: Used social media as normal
Number of subjects: 93
Study 33428901 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal life support (ECLS) in addition to early revascularization with percutaneous coronary intervention or coronary artery bypass grafting and optimal medical treatment
Number of subjects: 420
Study 33428901 — intervention group
Group type: COMPARATOR
Intervention: No ECLS
Number of subjects: 420
Study 33428901 — intervention group
Group type: EXPERIMENTAL
Intervention: ECLS
Number of subjects: 420
Study 36173031 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotics capsule plus anti-inflammatory-antioxidant rich diet
Number of subjects: 69
Study 36173031 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule plus dietary recommendations
Number of subjects: 69
Study 36173031 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotics and dietary intervention
Number of subjects: 69
Study 34184929 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone levels during androgen deprivation therapy (ADT)
Number of subjects: 0
Study 34184929 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant PSA values
Number of subjects: 0
Study 32065299 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-temperature plasma radiofrequency ablation (coblation)
Number of subjects: 95
Study 32065299 — intervention group
Group type: COMPARATOR
Intervention: Nd:YAG laser
Number of subjects: 95
Study 35373693 — intervention group
Group type: EXPERIMENTAL
Intervention: Needling/microneedling in conjunction with NB‐UVB phototherapy
Number of subjects: 20
Study 35373693 — intervention group
Group type: COMPARATOR
Intervention: NB‐UVB monotherapy
Number of subjects: 20
Study 34129067 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 329
Study 34129067 — intervention group
Group type: COMPARATOR
Intervention: Invasive coronary angiography (ICA)
Number of subjects: 329
Study 34959749 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavoured water (FW)
Number of subjects: 18
Study 34959749 — intervention group
Group type: COMPARATOR
Intervention: Plain water (W)
Number of subjects: 18